Table 1.
Study population. Clinical features of 102 patients with head and neck cancer who agreed to submit a histological sample for this study.
| Variable | Value | Count | Percent |
|---|---|---|---|
| Sex | male | 85 | 83% |
| female | 17 | 17% | |
| Age | ≤50 | 15 | 15% |
| 51–60 | 34 | 33% | |
| 61–70 | 32 | 31% | |
| 71–80 | 14 | 14% | |
| >80 | 7 | 7% | |
| Tumor site | lips/oral cavity | 10 | 10% |
| oropharynx | 49 | 48% | |
| hypopharynx | 19 | 19% | |
| Larynx | 19 | 19% | |
| other | 5 | 5% | |
| UICC stage | stage 1 | 10 | 10% |
| stage 2 | 10 | 10% | |
| stage 3 | 20 | 20% | |
| stage 4a | 49 | 48% | |
| stage 4b | 6 | 6% | |
| stage 4c | 7 | 7% | |
| P16 status | negative (<60%) | 74 | 73% |
| positive (≥60%) | 28 | 27% |